2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 1
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Neoplasms
18
Venous Thromboembolism
16
Venous Thrombosis
5
Pulmonary Embolism
4
Treatment of Venous Thromboembolism in Cancer Patients
3
Thrombosis
3
Multiple Myeloma
3
Upper Extremity Deep Vein Thrombosis
2
Lung Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Thromboembolism
1
Stomach Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Prevention of Venous Thromboembolism
1
Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Myeloproliferative Disorders
1
Lymphoma
1
Leukemia
1
Inflammation
1
Immune System Diseases
1
Hemorrhage
1
Hematologic Neoplasms
1
Interventions
Carboplatin
346
Cisplatin
240
Paclitaxel
208
Radiotherapy
207
Pemetrexed
190
Docetaxel
170
Gemcitabine
158
pembrolizumab
147
Erlotinib Hydrochloride
111
Magnetic Resonance Spectroscopy
102
Etoposide
99
Bevacizumab
96
Specimen Handling
84
Nivolumab
77
Radiosurgery
74
durvalumab
73
Blood Specimen Collection
65
Drug Therapy
61
osimertinib
56
Vinorelbine
54
Gefitinib
50
Surveys and Questionnaires
48
atezolizumab
45
Biopsy
43
Radiation
42
Irinotecan
42
Topotecan
39
Standard of Care
39
Cyclophosphamide
38
Surgical Procedures, Operative
35
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Rivaroxaban
×
Clear all
NCT06314763
2024-04-30
ROSIE
Radboud University Medical Center
Phase 4
Completed
21 enrolled
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled